Results 181 to 190 of about 10,317 (226)

Ocular myasthenia gravis

Russian Annals of Ophthalmology
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as ...
M.S. Sergeeva, S.S. Danilov, N.I. Sherbakova   +2 more
openaire   +3 more sources

Ocular Aspects of Myasthenia Gravis

Seminars in Neurology, 2000
Ocular myasthenia gravis is a not uncommon autoimmune disorder causing diplopia, ptosis, and weakness of lid closure. The predilection of myasthenia for the ocular muscles may be related to differences between limb and extraocular muscles in either physiological function or antigenicity. Clinically, ocular myasthenia can mimic any form of pupil-sparing
J J, Barton, M, Fouladvand
openaire   +2 more sources

Update on Ocular Myasthenia Gravis

Neurologic Clinics, 2017
Ocular myasthenia gravis (OMG) is a localized form of myasthenia gravis in which autoantibodies directed against acetylcholine receptors block or destroy these receptors at the postsynaptic neuromuscular junction. The hallmark of OMG is a history of painless weakness or fatigability of the extraocular muscles and ptosis with normal pupillary function ...
Stacy V, Smith, Andrew G, Lee
openaire   +2 more sources

Childhood ocular myasthenia gravis

Ophthalmology, 2003
To investigate the clinical manifestations and ocular findings in children with ocular myasthenia gravis (MG) that rarely have been reported in the literature.Retrospective, noncomparative case series.Twenty-four consecutive patients less than 15 years of age with ocular MG treated between June 1988 and July 2001.The medical records of 6 boys and 18 ...
Jong-Hyun, Kim, Jeong-Min, Hwang, Yong Seung, Hwang, Ki Joong, Kim, Jonghee, Chae   +4 more
openaire   +2 more sources

Treatment of Ocular Myasthenia Gravis

Current Treatment Options in Neurology, 2011
Myasthenia gravis (MG) is an autoimmune disorder that is characterized by variable weakness and fatigability. Often, MG presents with only ocular symptoms such as ptosis and diplopia. Treatment of ocular MG is aimed at relieving the symptoms of ptosis and diplopia, as well as preventing the development of generalized MG symptoms.
Scott R, Haines, Matthew J, Thurtell
openaire   +2 more sources

Update on Ocular Myasthenia Gravis

Seminars in Neurology, 2019
AbstractMyasthenia gravis is an antibody-mediated autoimmune disorder of the post-synaptic neuromuscular junction resulting in fluctuating, fatigable weakness. Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [OMG]
Meabh, O'Hare, Christopher, Doughty
openaire   +2 more sources

Pediatric Ocular Myasthenia Gravis

Current Treatment Options in Neurology, 2019
We present a review of current strategies in the treatment of pediatric ocular myasthenia gravis (OMG). A critical appraisal was performed of the current literature available on OMG and the treatment options available for all age populations. From this data, we present the evidence surrounding therapeutic options for pediatric OMG and discuss treatment
Kristen, Fisher, Veeral, Shah
openaire   +2 more sources

Myasthenia gravis: Antibodies to acetylcholine receptor in ocular myasthenia gravis

Journal of Neurology, 1981
To improve the sensitivity of the radioimmunoassay method for anti-AChR-antibody, large amounts of sera from patients with myasthenia gravis, and higher concentrations of antigens and rabbit anti-human-IgG-antiserum, were used. These procedures enabled measurement of the titre value of over 0.04 pmol/ml serum and this value revealed a sensitivity about
K, Oda, Y, Ito
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 1996
Ocular myasthenia gravis may mimic any pupil-spared, painless, nonproptotic ophthalmoplegia with or without ptosis. This review references recent papers regarding clinical features, diagnostic techniques, and treatment for ocular myasthenia gravis.
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 2018
Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time.
Elizabeth, Fortin, Dean M, Cestari, David H, Weinberg   +2 more
openaire   +2 more sources